Anika to Issue Third Quarter 2021 Financial Results on Thursday, November 4, 2021
Anika Therapeutics, Inc. (NASDAQ: ANIK) plans to release its third quarter 2021 financial results post-market on November 4, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Anika Therapeutics, Inc. (NASDAQ: ANIK) plans to release its third quarter 2021 financial results post-market on November 4, 2021. The company will hold an investor conference call at 5:00 p.m. ET the same day to discuss financial results and business highlights. Stakeholders can participate via dial-in or through a live audio webcast available on Anika's website. The call will be archived for later access. Anika specializes in joint preservation through innovations in orthopedic care, focusing on osteoarthritis management and regenerative solutions.
Positive
- Scheduled earnings release for Q3 2021 may indicate timely financial reporting.
- Investment community engagement through an investor conference call.
Negative
- None.
Details
News Market Reaction – ANIK
The recorded move for ANIK in the trading session of this news was -1.56%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BEDFORD, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its third quarter 2021 financial results after the close of the market on Thursday, November 4, 2021 and hold its investor conference call on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights.
The conference call can be accessed by dialing 1-800-437-2398 (toll-free domestic) or 1-856-344-9206 (international) and providing the conference ID number 8047540. A live audio webcast will be available in the Investor Relations section of Anika's website, www.anika.com. An accompanying slide presentation also can be accessed via the Anika website. The call will be archived and accessible on the same website shortly after its conclusion.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with physicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. For more information, please visit www.anika.com.
For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Executive Director, Investor Relations and Corporate Communications
investorrelations@anika.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.